A research study published in the British Medical Journal has looked at 274 comparative studies on flu vaccination with findings that only 18% had research to suggest the vaccine actually works.
Although 70% had conclusions that were favourable to the vaccines, only 18% of those were actually valid with over half of the studies (56%) showing high risk of bias and only 4% overall being at low risk.
Healthcare workers rarely have the time to analyse all research data to decide what is ‘best practice’ and how to treat their patients. They rely on prestigious medical journals such as the BMJ to inform them of the latest in drug and vaccine trials and medical research via studies, letters and editorials.
Many doctors in the field only have time to scan the material, in main seeking out the ‘abstract’ or ‘conclusions’ in the articles.
The more prestigious the journal, the more reliable it’s research articles are deemed to be. Not only this but as they are so highly regarded, the information they provide is often rehashed and regurgitated in other scientific journals and conferences, reinforcing the ‘proven’ effectiveness of various medications and vaccines.
The authors of the study in relation to the flu vaccine stated that “Studies partly or completely sponsored by industry, however, were published in more prestigious journals and are probably cited more, although their methodological quality and size were similar. Some of these findings might help explain the continuation of a near global policy, despite growing doubts as to its scientific basis”.
One of the key findings as to what scientific research makes it into these prestigious medical journals is that it has less to do with the quality of the research and far more to do with who’s paying for it.
The papers funded by major companies are far more likely to be published, despite research methodology or conclusions.
Tom Jefferson, lead author said ” The study shows that one of the levers for accessing prestigious journals is the financial size of your sponsor. Pharmaceutical sponsors order many reprints of studies supporting their products, often with in-house translations into many languages. They will also purchase publicity space in the journal. Many publishers openly advertise this space on their website”.
Makes you wonder doesn’t it?